Table 1. Clinical studies conducted in some dietary components in prostate cancer.
Dietary component | Finding | Reference |
---|---|---|
Vitamin E | ↓Risk of prostate cancer and aggressive disease | [50] |
↓PSA serum levels in recurrent prostate cancer patients | [51] | |
Maintain stable disease and median progression-free survival of 2.8 months in patients with castrate-resistant prostate cancer | [52] | |
↑Risk of prostate cancer (>7 times/wk) | [53] | |
↑High-grade of prostate cancer | [54] | |
No effect on prostate cancer and BPH | [55,56] | |
Carotenoids | ↑Incidence of prostate cancer (20 mg/d) | [60] |
Not associated with prostate cancer (30 mg or 50 mg) | [61,62] | |
Not associated with prostate cancer | [50] | |
Vitamin D | ↑Prostate cancer in certain subpopula-tions (<20 ng/mL) | [65] |
↓Aggressive prostate cancer | [66] | |
↓Risk of prostate cancer | [67] | |
↓IL-8 and CRP in patients with prostate cancer | ||
↓CRP in prostate cancer patients | [68] | |
↑Risk of prostate cancer | [70] | |
Zinc | ↑4.36-fold of developing fatal prostate cancer | [53] |
Selenium | ↓Prostate cancer susceptibility | [72] |
↓Risk of aggressive prostate cancer | [73] | |
No effect | [74,75] | |
Flavonoids | ↓Prostate cancer | [76] |
Dietary fiber | ↓Total and advanced prostate cancer | [77,78,79,80] |
No effect | [81,82] |
PSA: prostate-specific antigen, BPH: benign prostatic hyperplasis, IL: interleukin, CRP: C-reactive protein.